e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Is it really asthma?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bronchial asthma (BA) pharmacogenetic profile and therapeutic resistance in slavic population
Z. Mironova, V. Trofimov, M. Dubina, V. Belash, A. Ulitina (Saint-Petersburg, Russian Federation)
Source:
Annual Congress 2013 –Is it really asthma?
Session:
Is it really asthma?
Session type:
Oral Presentation
Number:
359
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. Mironova, V. Trofimov, M. Dubina, V. Belash, A. Ulitina (Saint-Petersburg, Russian Federation). Bronchial asthma (BA) pharmacogenetic profile and therapeutic resistance in slavic population. Eur Respir J 2013; 42: Suppl. 57, 359
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Clinical phenotypes in asthmatic population with severe asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
ADEPT, airway disease endotyping for personalized treatment: Interim analysis of asthma patients
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013
Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma
Source: Annual Congress 2013 –Genetic factors in airway development and disease
Year: 2013
Overlap phenotypes of asthma in adults: Obesity and atopy
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Phenotypic characteristics of asthma with small airways involvement
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Usefulness of periostin as a biomarker of pediatric asthma
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015
U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013
A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Impact of the genetic variation of GLCCI1 on clinical features of asthmatic patinets
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016
Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Small airway indices, bronchodilator response and asthma control in children
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014
Refined severity assessment of asthmatic children using molecular allergy diagnostics
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
The clinical and genetic factors for predicting the response to inhaled corticosteroids
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
Genetic polymorphisms in early and late-onset bronchial asthma
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Novel proteomic biomarkers in the evaluation of childhood asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
The potential role of bronchial challenge testing to identify overtreatment of community managed asthma
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014
Biomarkers of asthma severity in the gene environment interaction in respiratory disease (GEIRD) study
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
U-BIOPRED: Clinical characteristics of children with severe asthma (SA) and severe pre-school wheeze (SPSW)
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Study of the correlations between FENO and atopic status, blood eosinophils, FCER2 mutation, and asthma control in Vietnamese children
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016
Novel asthma definition for epidemiological studies
Source: Annual Congress 2013 –Epidemiology of asthma
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept